India’s first stem cell drug Stempeucel to hit market by fiscal end – Livemint
Livemint |
India's first stem cell drug Stempeucel to hit market by fiscal end
Livemint New Delhi: India's first stem cell drug Stempeucel could be in the market by the end of the financial year. The drug, made by Stempeutics Research, a firm part-owned by Cipla Ltd, will treat Buerger's Disease, a rare condition of reduced blood flow to … |
